Suchergebnisse - "Banach, Maciej"

PubPharm (73)

1

Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?

enthalten in: Current atherosclerosis reports | 2024

von Surma, S. | Sahebkar, A. | Banach, M.

ErratumIn: Curr Atheroscler Rep. 2024 Jan 22;:. - PMID 38252373

2

Evaluation of the efficacy and safety of bempedoic acid in women and men : Pooled analyses from phase 3 trials

enthalten in: Atherosclerosis | 2023

von Goldberg, A. | Banach, M. | Catapano, A. | +5

3

Rhabdomyolysis or Severe Acute Hepatitis Associated with the Use of Red Yeast Rice Extracts : an Update from the Adverse Event Reporting Systems

enthalten in: Current atherosclerosis reports | 2023

von Banach, M. | Norata, G.

4

Metabolic syndrome is associated with similar long-term prognosis in those living with and without obesity : an analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 studies

enthalten in: European journal of preventive cardiology | 2023

von Osadnik, K. | Osadnik, T. | Gierlotka, M. | +19

CommentIn: Eur J Prev Cardiol. 2023 May 09;:. - PMID 37158487

5

Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)

enthalten in: Progress in cardiovascular diseases | 2023

von Banach, M. | Penson, P. | Farnier, M. | +9

6

Killing the Culprit : Pharmacological Solutions to Get Rid of Cholesterol Crystals

enthalten in: Current problems in cardiology | 2022

von Iranshahy, M. | Banach, M. | Hasanpour, M. | +2

7

Red yeast rice for dyslipidaemias and cardiovascular risk reduction : A position paper of the International Lipid Expert Panel

enthalten in: Pharmacological research | 2022

von Banach, M. | Catapano, A. | Cicero, A. | +10

8

Negatively-charged Liposome Nanoparticles Can Prevent Dyslipidemia and Atherosclerosis Progression in the Rabbit Model

enthalten in: Current vascular pharmacology | 2022

von Momtazi-Borojeni, A. | Abdollahi, E. | Jaafari, M. | +3

9

EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care : the DA VINCI study

enthalten in: European journal of preventive cardiology | 2021

von Ray, K. | Molemans, B. | Schoonen, W. | +28

10

Nutraceuticals in the Management of Dyslipidemia : Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

enthalten in: Current atherosclerosis reports | 2021

von Cicero, A. | Fogacci, F. | Stoian, A. | +5

1
2
3
4
5
6
7
8
Nächster »
[8]